Machine-Learning-Based Clinical Biomarker Using Cell-Free DNA for Hepatocellular Carcinoma (HCC)

Machine-Learning-Based Clinical Biomarker Using Cell-Free DNA for Hepatocellular Carcinoma (HCC)

(1) Background: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. Although various serum enzymes have been utilized for the diagnosis and prognosis of HCC, the currently available biomarkers lack the sensitivity needed to detect HCC at early stages and ac...

Full description

Bibliographic Details
Main Authors: Taehee Lee, Piper A. Rawding, Jiyoon Bu, Sunghee Hyun, Woosun Rou, Hongjae Jeon, Seokhyun Kim, Byungseok Lee, Luke J. Kubiatowicz, Dawon Kim, Seungpyo Hong, Hyuksoo Eun
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Cancers
Subjects:
cell-free DNA (cfDNA)
circulating tumor DNA (ctDNA)
hepatocellular carcinoma (HCC)
liquid biopsy
principal component analysis (PCA)
Online Access:https://www.mdpi.com/2072-6694/14/9/2061

Internet

https://www.mdpi.com/2072-6694/14/9/2061

Similar Items